Stocks News

LAST PRICE
309.1100
TODAY'S CHANGE (%)
Trending Down-0.7100 (-0.2292%)

Bid / Lots
308.7900/ 5
Ask / Lots
310.0000/ 4
Open / Previous Close
307.4400 / 309.8200
Day Range
Low 307.4400
High 309.6550
52 Week Range
Low 215.9600
High 335.8300
Volume
15,580
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ HCA Healthcare Is Maintained at Buy by TD Cowen, from 22 hours ago by Dow Jones
  22 hours ago by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 30, 2024 11:19 ET (15:19 GMT)
- TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371, from 7:01AM ET on Tuesday Apr 30, 2024 by MT Newswires
  7:01AM ET on Tuesday Apr 30, 2024 by MT Newswires
  Companies Mentioned: HCA
  07:01 AM EDT, 04/30/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
Apr 29, 2024
- DJ HCA Healthcare Is Maintained at Overweight by Barclays, from 11:51AM ET on Monday Apr 29, 2024 by Dow Jones
  11:51AM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 11:51 ET (15:51 GMT)
- DJ HCA Healthcare Is Maintained at Outperform by RBC Capital, from 10:17AM ET on Monday Apr 29, 2024 by Dow Jones
  10:17AM ET on Monday Apr 29, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 10:17 ET (14:17 GMT)
- Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354, from 9:29AM ET on Monday Apr 29, 2024 by MT Newswires
  9:29AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: HCA
  09:29 AM EDT, 04/29/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average outperform rating and a price target range of $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ...

Today
- Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI, from 2 hours ago by PR Newswire
  2 hours ago by PR Newswire
  Companies Mentioned: DGX
Yesterday
- Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244, from 8:41AM ET on Tuesday Apr 30, 2024 by MT Newswires
  8:41AM ET on Tuesday Apr 30, 2024 by MT Newswires
  Companies Mentioned: LH
- Baird Adjusts Quest Diagnostics' Price Target to $144 From $138, from 8:37AM ET on Tuesday Apr 30, 2024 by MT Newswires
  8:37AM ET on Tuesday Apr 30, 2024 by MT Newswires
  Companies Mentioned: DGX
- BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating, from 5:16AM ET on Tuesday Apr 30, 2024 by MT Newswires
  5:16AM ET on Tuesday Apr 30, 2024 by MT Newswires
  Companies Mentioned: WELL
Apr 29, 2024
- Welltower Q1 Normalized FFO, Revenue Increase, from 4:47PM ET on Monday Apr 29, 2024 by MT Newswires
  4:47PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: WELL
- -- Earnings Flash (WELL) WELLTOWER Posts Q1 Revenue $1.86B, from 4:23PM ET on Monday Apr 29, 2024 by MT Newswires
  4:23PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: WELL
- Equities Higher as Traders Await This Week's Key Earnings, Fed Decision, from 3:46PM ET on Monday Apr 29, 2024 by MT Newswires
  3:46PM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: WELL, KO, LLY, LOGI, MCD, PFE, NXPI, AAPL, PARA, PARAA, AMD, AMZN, MA
- Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy, from 10:17AM ET on Monday Apr 29, 2024 by MT Newswires
  10:17AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: LH, PFE
- Evercore ISI Adjusts Price Target on Ventas to $49 From $50, from 7:40AM ET on Monday Apr 29, 2024 by MT Newswires
  7:40AM ET on Monday Apr 29, 2024 by MT Newswires
  Companies Mentioned: VTR
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 7:03AM ET on Monday Apr 29, 2024 by PR Newswire
  7:03AM ET on Monday Apr 29, 2024 by PR Newswire
  Companies Mentioned: LH

HCA Healthcare Inc
NYSE:HCAUnited States

Search Criteria

Yesterday

DJ HCA Healthcare Is Maintained at Buy by TD Cowen, from 22 hours ago by Dow Jones

TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371, from 7:01AM ET on Tuesday Apr 30, 2024 by MT Newswires

Apr 29, 2024

DJ HCA Healthcare Is Maintained at Overweight by Barclays, from 11:51AM ET on Monday Apr 29, 2024 by Dow Jones

DJ HCA Healthcare Is Maintained at Outperform by RBC Capital, from 10:17AM ET on Monday Apr 29, 2024 by Dow Jones

Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354, from 9:29AM ET on Monday Apr 29, 2024 by MT Newswires

Peers Headlines

Today

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI, from 2 hours ago by PR Newswire

Yesterday

Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244, from 8:41AM ET on Tuesday Apr 30, 2024 by MT Newswires

Baird Adjusts Quest Diagnostics' Price Target to $144 From $138, from 8:37AM ET on Tuesday Apr 30, 2024 by MT Newswires

BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating, from 5:16AM ET on Tuesday Apr 30, 2024 by MT Newswires

Apr 29, 2024

Welltower Q1 Normalized FFO, Revenue Increase, from 4:47PM ET on Monday Apr 29, 2024 by MT Newswires

-- Earnings Flash (WELL) WELLTOWER Posts Q1 Revenue $1.86B, from 4:23PM ET on Monday Apr 29, 2024 by MT Newswires

Equities Higher as Traders Await This Week's Key Earnings, Fed Decision, from 3:46PM ET on Monday Apr 29, 2024 by MT Newswires

Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy, from 10:17AM ET on Monday Apr 29, 2024 by MT Newswires

Evercore ISI Adjusts Price Target on Ventas to $49 From $50, from 7:40AM ET on Monday Apr 29, 2024 by MT Newswires

Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 7:03AM ET on Monday Apr 29, 2024 by PR Newswire